Enzyme inhibitors and enzyme substrates

Camostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and matriptase.A protease and Trypsin inhibitor.

Camostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and matriptase.A protease and Trypsin inhibitor.

Camostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and matriptase.A protease and Trypsin inhibitor.

Camostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and matriptase.A protease and Trypsin inhibitor.

Captopril is a reversible and competitive inhibitor of leukotriene A4 hydrolase (LTA4H: IC50 = 11μM). Captopril has been shown to be an inhibitor of angiotensin converting enzyme-1 (ACE1), but not ACE2 (IC50 = 22 nM). Captopril demonstrates

Captopril is a reversible and competitive inhibitor of leukotriene A4 hydrolase (LTA4H: IC50 = 11μM). Captopril has been shown to be an inhibitor of angiotensin converting enzyme-1 (ACE1), but not ACE2 (IC50 = 22 nM). Captopril demonstrates

Captopril is a reversible and competitive inhibitor of leukotriene A4 hydrolase (LTA4H: IC50 = 11μM). Captopril has been shown to be an inhibitor of angiotensin converting enzyme-1 (ACE1), but not ACE2 (IC50 = 22 nM). Captopril demonstrates

Captopril is a reversible and competitive inhibitor of leukotriene A4 hydrolase (LTA4H: IC50 = 11μM). Captopril has been shown to be an inhibitor of angiotensin converting enzyme-1 (ACE1), but not ACE2 (IC50 = 22 nM). Captopril demonstrates

Captopril is a reversible and competitive inhibitor of leukotriene A4 hydrolase (LTA4H: IC50 = 11μM). Captopril has been shown to be an inhibitor of angiotensin converting enzyme-1 (ACE1), but not ACE2 (IC50 = 22 nM). Captopril demonstrates

Celecoxib is a selective COX-2 inhibitor with IC50 of 40 nM.A selective Cox-2 inhibitor.

Celecoxib is a selective COX-2 inhibitor with IC50 of 40 nM.A selective Cox-2 inhibitor.

Celecoxib is a selective COX-2 inhibitor with IC50 of 40 nM.A selective Cox-2 inhibitor.